Vectorite Biomedical Inc. (TPEX:4170)

Taiwan · Delayed Price · Currency is TWD

13.40

-0.10 (-0.74%)

May 29, 2026, 12:26 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology			55.85M	42.91M	28.77M	24.54M	26.54M
Biotechnology Growth			30.15%	49.16%	17.22%	-7.52%	-87.14%
Total			55.85M	42.91M	28.77M	24.54M	26.54M
Total Growth			30.15%	49.16%	17.22%	-7.52%	-87.14%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan			55.85M	42.91M	28.76M	24.54M	25.23M
Taiwan Growth			30.15%	49.21%	17.22%	-2.77%	-86.56%
Asia			-	-	9.00K	9.00K	1.31M
Asia Growth			-	-	0%	-99.31%	-92.96%
Total			55.85M	42.91M	28.77M	24.54M	26.54M
Total Growth			30.15%	49.16%	17.22%	-7.52%	-87.14%

Source: S&P Global Market Intelligence.